BullFrog AI's stock is showing a strong bullish trend, with a massive spike on April 11 (close: $2.10, up ~49% from the previous day) backed by explosive volume (13.5M vs. avg. low thousands). The 9-day EMA crossed above the 21-day, signaling momentum. RSI hit 74.38—approaching overbought but not extreme. Positive news (funding, partnerships, symposiums) likely fueled the rally. Short-term? 🚀 But watch for a pullback if RSI stays elevated. Hold if bullish, take profits if cautious. Fun times for AI penny stocks!

BullFrog AI Holdings, Inc., through its subsidiaries, operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. It offers bfLEAP, an AI/ML platform for the analysis of preclinical and/or clinical data. The company also has licensing agreements with George Washington University for rights to use siRNA targeting Beta2-spectrin in the treatment of human diseases, including hepatocellular carcinoma, obesity, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis; and Johns Hopkins University for the use of a formulation of Mebendazole for the treatment of human cancer or neoplastic disease. BullFrog AI Holdings, Inc. was founded in 2017 and is based in Gaithersburg, Maryland.

Bullfrog AI Holdings, Inc. Common Stock BFRG: 1.66 USD

Bullish views